Join
Live feed
·
INSIDERFilingvia Quantisnow
Avidity Biosciences Inc. logo

President and CEO Boyce Sarah returned 474,861 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNAM· Avidity Biosciences Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNAM (Avidity Biosciences Inc.) and more on Quantisnow.